Barrow Hanley Mewhinney & Strauss LLC Bristol Myers Squibb CO Transaction History

Barrow Hanley Mewhinney & Strauss LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $3.56 Million - $3.92 Million	-49,057 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $489,257 - $586,663	-7,958 Reduced 13.96%	49,057 $3.58 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $76,506 - $89,617	-1,293 Reduced 2.22%	57,015 $3.37 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $224,857 - $244,869	-3,632 Reduced 5.86%	58,308 $3.9 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $157,013 - $176,594	-2,646 Reduced 4.1%	61,940 $3.91 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $542,120 - $614,322	9,389 Added 17.01%	64,586 $4.01 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $1.59 Million - $1.76 Million	-27,684 Reduced 33.4%	55,197 $3.33 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $5,336 - $7,754	115 Added 0.14%	82,881 $4.62 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $32.4 Million - $42.3 Million	-658,421 Reduced 88.83%	82,766 $5.31 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.43 Million - $1.69 Million	-33,390 Reduced 4.31%	741,187 $37.6 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $1.15 Million - $1.27 Million	-25,758 Reduced 3.22%	774,577 $35.1 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $36.1 Million - $43.1 Million	800,335 New	800,335 $38.2 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.